Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Pharm (Weinheim) ; 357(6): e2400061, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38631672

ABSTRACT

Fragment-based screening has become indispensable in drug discovery. Yet, the weak binding affinities of these small molecules still represent a challenge for the reliable detection of fragment hits. The extent of this issue was illustrated in the literature for the aspartic protease endothiapepsin: When seven biochemical and biophysical in vitro screening methods were applied to screen a library of 361 fragments, very poor overlap was observed between the hit fragments identified by the individual approaches, resulting in high levels of false positive and/or false negative results depending on the mutually compared methods. Here, the reported in vitro findings are juxtaposed with the results from in silico docking and scoring approaches. The docking programs GOLD and Glide were considered with the scoring functions ASP, ChemScore, ChemPLP, GoldScore, DSXCSD, and GlideScore. First, the ranking power and scoring power were assessed for the named scoring functions. Second, the capability of reproducing the crystallized fragment binding modes was tested in a structure-based redocking approach. The redocking success notably depended on the ligand efficiency of the considered fragments. Third, a blinded virtual screening approach was employed to evaluate whether in silico screening can compete with in vitro methods in the enrichment of fragment databases.


Subject(s)
Aspartic Acid Endopeptidases , Molecular Docking Simulation , Aspartic Acid Endopeptidases/antagonists & inhibitors , Aspartic Acid Endopeptidases/metabolism , Aspartic Acid Endopeptidases/chemistry , Ligands , Drug Discovery , Structure-Activity Relationship , Protein Binding , Computer Simulation , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology
2.
Chemistry ; 27(70): 17660-17668, 2021 Dec 15.
Article in English | MEDLINE | ID: mdl-34596278

ABSTRACT

The parent borylene (CAAC)(Me3 P)BH, 1 (CAAC=cyclic alkyl(amino)carbene), acts both as a Lewis base and one-electron reducing agent towards group 13 trichlorides (ECl3 , E=B, Al, Ga, In), yielding the adducts 1-ECl3 and increasing proportions of the radical cation [1]•+ for the heavier group 13 analogues. With boron trihalides (BX3 , X=F, Cl, Br, I) 1 undergoes sequential adduct formation and halide abstraction reactions to yield borylboronium cations and shows an increasing tendency towards redox processes for the heavier halides. Calculations confirm that 1 acts as a strong Lewis base towards EX3 and show a marked increase in the B-E bond dissociation energies down both group 13 and the halide group.

SELECTION OF CITATIONS
SEARCH DETAIL
...